INTRODUCTION AND OBJECTIVES: Periprostatic fat (PPF) is a well-vascularized adipose tissue that encloses the prostate containing resident adipose tissue macrophages (ATM) that are mobilized and recruited to areas with high tissue remodeling. PPF can secrete a wide range of adipokines involved in physiologic and pathologic processes. It is well established that the unbalanced production of pro-inflammatory adipokines is a key component to the development of the metabolic syndrome, a risk factor for lower urinary tract symptoms (LUTS) and BPH progression. However, the link between PPF and BPH pathogenesis has not been previously addressed. In this study, we hypothesize that during BPH progression, PPF secretes a pro-inflammatory cytokine profile leading to chronic activation of NF-kB signaling pathway METHODS: PPF was collected from patients undergoing prostatectomy. The thickness of PPF was determined (distance between the pubic symphysis and prostate) in 205 patients using MRI and classified based on their BMI (lean vs. obese). The composition of PPF was characterized histopathologically with emphasis on the immune/inflammatory infiltrates. To determine the factors secreted by PPF, a short in vitro culture was used to generated conditioned medium and adipocytokine array analysis performed. Proliferation of benign prostate epithelial and stromal cells exposed to PPF-CM was assessed. Upon exposure to PPF-CM, activation of the NF-kB pathway was determined by western blot analysis. In vivo experiments were performed xenografting PPF and human prostate tissues under the kidney capsule of SCID mice to determine the effects of PPF on prostate histology and recruitment of inflammatory cells RESULTS: Histological analysis of human PPF samples showed an increased ratio of multilocular/unilocular phenotype composed mainly of macrophages and mononuclear infiltrates in obese individuals compared to the unilocular pattern and lack of inflammatory infiltrates in lean patients. Obese patients showed a significantly increased PPF thickness (more than double) compared to lean patients. Interestingly MRI showed that PPF only partially surrounds the prostate in lean patients, while fat tissue almost completely encased the prostate in obese individuals. Adipokine array assays from PPF-CM samples show the expression of a profile of pro-inflammatory factors. Addition of androgens modulated the secretion of IL11, TGFb1, IL16 and SDF1a, among oth CONCLUSIONS: Our preliminary studies suggest a potential role for the PPF pro-inflammatory secretome in BPH pathogenesis
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MP17-19 THE EXPRESSION AND FUNCTIONAL ACTIVITIES OF SMOOTH MUSCLE MYOSIN AND NON-MUSCLE MYOSIN ISOFORMS IN RAT PROSTATE
Ping Chen, Jing Yin, Yuming Guo, Xinghuan Wang, Wuhan, China, People's Republic of; Michael E DiSanto, Camden, NJ; Xinhua Zhang*, Wuhan, China, People's Republic of INTRODUCTION AND OBJECTIVES: Benign prostatic hyperplasia (BPH) is a common disease in aging male, which mainly caused by increased prostatic smooth muscle (SM) tone and volume. Lowering SM tone with a-blockers are one of the most effective treatment for BPH. SM and non-muscle (NM) myosin play important roles mediating SM tone and cell proliferation. But it was less studied in the prostate.
METHODS: Rat prostate and cultured primary human prostate SM and epithelial cells were used. In vitro organ bath studies were performed to explore contractility of rat prostate, corpus cavernosum, bladder and aorta. SMM isoforms were determined with competitive RT-PCR. SM myosin heavy chain (MHC) and NM MHC isoforms (NMHC-A, NMHC-B and NMHC-C) were further analyzed with Western Blot and immunofluorescence.
RESULTS: SM MHC was abundantly displayed in rat prostate, predominantly in the outer stroma layer. Prostatic SM generated significant force in response to KCl depolarization and phenylephrine (PE)-mediated stimulation in a dose-dependent manner with an intermediate tonicity between bladder typical phasic and aorta tonic contractility. And time to 50% PE mediated maximum contraction of prostate (13.2AE2.6 S) was between that of bladder (5.7AE1.2 S) and aorta (24.2AE2.4 S). Correlated with this kind of intermediate tonicity, rat prostate mainly expressed LC 17a and SM1 but with relatively equal expression of SM-B at the mRNA level. Meanwhile, isoforms of NMHC-A, B, C were also abundantly detected in the prostate with SMM present only in SM cells, NMHC-A and NMHC-B both present in SM and endothelial cells, and NMHC-C expressed only in the SM cells. Furthermore, NM expression in rat prostate was more than 2-fold higher than that of rat bladder, while SMM expression was found to be similar. Additionally, SMM specific inhibitor Blebbistatin could potently relax PE pre-contracted prostate SM, comparable to the effect of sodium nitroprusside (nitric oxide donor) and H-1152 (a specific, strong and membrane-permeable inhibitor of Rho-kinase)
CONCLUSIONS: Our novel data demonstrated the expression and functional activities of SMM and NM isoforms in the rat prostate. It is suggested that the isoforms of SMM and NM could play important roles in BPH development. 
MP17-20 PHOSPHODIESTERASE TYPE 5 (PDE5) IN THE HUMAN PROSTATE: RELATION TO KEY ENZYMES OF THE NITRIC OXIDE/CYCLIC GMP SIGNALING

INTRODUCTION AND OBJECTIVES:
The significance of the nitric oxide (NO)/cyclic GMP pathway in the control of prostate smooth musculature actually serves as a rationale for the clinical development of the phosphodiesterase type 5 (PDE5, cyclic GMP PDE) inhibitor tadalafil to treat lower urinary tract symptomatology (LUTS) secondary to benign prostatic hyperplasia (BPH). However, the potential relevance of the nitric oxide (NO)/cyclic GMP signaling in the human prostate is still discussed controversly. For example, it has been speculated that the clinical efficacy of PDE5 inhibitors in patients with LUTS/BPH can be explained by the effects of this class of drugs on the urinary bladder rather than the prostate (Chapple C.R., Roehrborn C.G., Eur. Urol. 49: 651-659, 2006) . This prompted us to evaluate in the human prostate the expression of key proteins of the NO pathway, namely the neuronal nitric oxide synthase (nNOS), cyclic GMP, and cyclic GMP-binding protein kinase type I (isoforms alpha und beta ¼ cGKIa, cGKIb), in relation to the PDE5.
METHODS: Slices (10 mm) of specimens taken from the transition zone (TZ) of the human prostate were exposed to antibodies directed against cyclic GMP, PDE5A, nNOS, cGKIa or cGKIb, followed by the application of fluorochrome-labeled secondary antibodies. Visualization was commenced by means of laser fluorescence microscopy.
RESULTS: In the smooth muscle (SM) portion of the TZ, immunosignals specific for the PDE5 were found co-localized with cyclic GMP, cGKIa and cGKIb, as well as with the cyclic cAMP-binding protein kinase A (cAK). SM bundles were seen innervated by slender varicose nerve fibers characterized by the expression of nNOS. Some of these nerves also presented staining related to the neuropeptide VIP (vasoactive intestinal polypeptide).
CONCLUSIONS: The results are in support of the hypothesis of a role of the cyclic GMP signaling in the control of the TZ of the prostate and also give hints that the cyclic GMP-and cyclic AMP-dependent signal transduction may synergistically work together.
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